1. Home
  2. CHMG vs CERS Comparison

CHMG vs CERS Comparison

Compare CHMG & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHMG
  • CERS
  • Stock Information
  • Founded
  • CHMG 1833
  • CERS 1991
  • Country
  • CHMG United States
  • CERS United States
  • Employees
  • CHMG N/A
  • CERS N/A
  • Industry
  • CHMG Major Banks
  • CERS EDP Services
  • Sector
  • CHMG Finance
  • CERS Technology
  • Exchange
  • CHMG Nasdaq
  • CERS Nasdaq
  • Market Cap
  • CHMG 239.3M
  • CERS 255.0M
  • IPO Year
  • CHMG N/A
  • CERS 1997
  • Fundamental
  • Price
  • CHMG $52.50
  • CERS $1.23
  • Analyst Decision
  • CHMG Hold
  • CERS Strong Buy
  • Analyst Count
  • CHMG 3
  • CERS 2
  • Target Price
  • CHMG $56.33
  • CERS $3.50
  • AVG Volume (30 Days)
  • CHMG 8.1K
  • CERS 1.1M
  • Earning Date
  • CHMG 10-21-2025
  • CERS 10-29-2025
  • Dividend Yield
  • CHMG 2.41%
  • CERS N/A
  • EPS Growth
  • CHMG N/A
  • CERS N/A
  • EPS
  • CHMG 2.38
  • CERS N/A
  • Revenue
  • CHMG $82,641,000.00
  • CERS $192,510,000.00
  • Revenue This Year
  • CHMG N/A
  • CERS $22.02
  • Revenue Next Year
  • CHMG $32.65
  • CERS $9.32
  • P/E Ratio
  • CHMG $22.31
  • CERS N/A
  • Revenue Growth
  • CHMG N/A
  • CERS 13.25
  • 52 Week Low
  • CHMG $40.71
  • CERS $1.12
  • 52 Week High
  • CHMG $55.73
  • CERS $2.24
  • Technical
  • Relative Strength Index (RSI)
  • CHMG 50.40
  • CERS 45.54
  • Support Level
  • CHMG $52.20
  • CERS $1.17
  • Resistance Level
  • CHMG $52.94
  • CERS $1.27
  • Average True Range (ATR)
  • CHMG 0.76
  • CERS 0.06
  • MACD
  • CHMG -0.16
  • CERS -0.00
  • Stochastic Oscillator
  • CHMG 11.67
  • CERS 33.33

About CHMG Chemung Financial Corp

Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: